Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Enantiomerically pure cis-and trans-5-alkyl-l-benzoyl-2-(tert-butyl)-~~-methylimidazolidin-4-ones (1, 2, 11, 15, 16) and trans-2-(terf-butyl)-3-methyl-5-phenylimidazolidin-4-one (20). readily available from (S)-alanine, (S)-valine, (S)-methionine, and (R)-phenylglycine are deprotonated to chiral enolates (cf. 3, 4, 12, 21). Diastereoselective alkylation of these enolates to 5,5-dialkyl-or 5-alkyl-5-arylimidazolidinones (5, 6, 9, 10, 13a-d, 17, 18, 22) and hydrolysis give a-alkyl-a-amino acids such as (R)and (S)-a-methyldopa (7 and 8a, resp.), (S)-amethylvaline (14) and (R)-a-methyl-methionine (19). The configuration of the products is proved by chemical correlation and by NOE 'H-NMR measurements (see 23, 24). In the overall process, a simple, enantiomerically pure a-amino acid can be a-alkylated with retention or with inversion of configuration through pivalaldehyde acetal derivatives. Since no chiral auxiliary is required, the process is coined 'self-reproduction of a center of chirality'. The method is compared with other a-alkylations of amino acids occurring without racemization. The importance of enantiomerically pure, a-branched a-amino acids as synthetic intermediates and for the preparation of bio~ogicdl~y active compounds is discussed.In [l], we have shown that simple amino acids such as (S)-alanine, (S)-valine, (R)-phenylglycine, (S)-phenylalanine, and (S)-methionine can be converted selectively to imidazolidinones such as 1 and 2 of either cis-or trans-configuration. We now show that these imidazolidinones are deprotonated to synthetically useful chiral enolates.A) Reactions of the Chiral Imidazolidinone Enolates with Electrophiles. -As a first example, the preparation of ( R ) -or (S)-a -methyldopa ( =I 2-amino-2-methyl-3-(3,4-di-hydroxypheny1)propionic acid) from (S)-alanine is described (Scheme I). Solutions of the imidazolidinones (1 or 2) in THF were treated at dry-ice temperature with a slight excess of lithium diisopropylamide (LDA). Bright orange-red-colored solutions of the enantiomeric enolates (3, 4) were formed, which were combined with 3,4-dimethoxybenzyl bromide. Rapid decolorization indicated the progress of the alkylation step furnishing the enantiomeric 5,5-disubstituted imidazolidinones (5, 6, ca. 60 YO). We did not detect more than one diastereoisomer by HPLC of the crude products. Within experimental error, the two isomers 5 and 6 had identical physical properties such as melting points, IR, and NMR spectra, but an opposite sense of specific rotation.The heterocyclic ring and the phenolic methyl-ether groups of the enantiomer 6 were cleaved by heating for 4 hours in 6~ HC1 at 180" in a sealed tube. Isolation of the a-methyldopa thus produced caused considerable problems due to the known [2a] sen-') 2,Part of the projected Ph. D. theses of J.
Enantiomerically pure cis-and trans-5-alkyl-l-benzoyl-2-(tert-butyl)-~~-methylimidazolidin-4-ones (1, 2, 11, 15, 16) and trans-2-(terf-butyl)-3-methyl-5-phenylimidazolidin-4-one (20). readily available from (S)-alanine, (S)-valine, (S)-methionine, and (R)-phenylglycine are deprotonated to chiral enolates (cf. 3, 4, 12, 21). Diastereoselective alkylation of these enolates to 5,5-dialkyl-or 5-alkyl-5-arylimidazolidinones (5, 6, 9, 10, 13a-d, 17, 18, 22) and hydrolysis give a-alkyl-a-amino acids such as (R)and (S)-a-methyldopa (7 and 8a, resp.), (S)-amethylvaline (14) and (R)-a-methyl-methionine (19). The configuration of the products is proved by chemical correlation and by NOE 'H-NMR measurements (see 23, 24). In the overall process, a simple, enantiomerically pure a-amino acid can be a-alkylated with retention or with inversion of configuration through pivalaldehyde acetal derivatives. Since no chiral auxiliary is required, the process is coined 'self-reproduction of a center of chirality'. The method is compared with other a-alkylations of amino acids occurring without racemization. The importance of enantiomerically pure, a-branched a-amino acids as synthetic intermediates and for the preparation of bio~ogicdl~y active compounds is discussed.In [l], we have shown that simple amino acids such as (S)-alanine, (S)-valine, (R)-phenylglycine, (S)-phenylalanine, and (S)-methionine can be converted selectively to imidazolidinones such as 1 and 2 of either cis-or trans-configuration. We now show that these imidazolidinones are deprotonated to synthetically useful chiral enolates.A) Reactions of the Chiral Imidazolidinone Enolates with Electrophiles. -As a first example, the preparation of ( R ) -or (S)-a -methyldopa ( =I 2-amino-2-methyl-3-(3,4-di-hydroxypheny1)propionic acid) from (S)-alanine is described (Scheme I). Solutions of the imidazolidinones (1 or 2) in THF were treated at dry-ice temperature with a slight excess of lithium diisopropylamide (LDA). Bright orange-red-colored solutions of the enantiomeric enolates (3, 4) were formed, which were combined with 3,4-dimethoxybenzyl bromide. Rapid decolorization indicated the progress of the alkylation step furnishing the enantiomeric 5,5-disubstituted imidazolidinones (5, 6, ca. 60 YO). We did not detect more than one diastereoisomer by HPLC of the crude products. Within experimental error, the two isomers 5 and 6 had identical physical properties such as melting points, IR, and NMR spectra, but an opposite sense of specific rotation.The heterocyclic ring and the phenolic methyl-ether groups of the enantiomer 6 were cleaved by heating for 4 hours in 6~ HC1 at 180" in a sealed tube. Isolation of the a-methyldopa thus produced caused considerable problems due to the known [2a] sen-') 2,Part of the projected Ph. D. theses of J.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.